When the U.S. Food and Drug Administration cleared for the first time a surgical device that can be assembled and disassembled inside a patient’s body, not a lot of people noticed.That’s probably because the manufacturer, a Cincinnati-based surgical products division of Johnson & Johnson called Ethicon Endo-Surgery, hasn’t yet launched the product — and maybe [...]

Cardiology medical device company AtriCure (NASDAQ:ATRC) is aiming to begin in the fourth quarter a clinical trial investigating its AtriClip device in the treatment of stroke patients.Before that can happen, though, the Cincinnati-area company must complete development of a next-generation version of the AtriClip, a device used to exclude the left atrial appendage during cardiac [...]

Meridian Bioscience‘s (NASDAQ:VIVO) has two molecular diagnostic tests in clinical trials, with another test expected to begin trials later in the year.Currently in trials are tests built on the company’s illumigene molecular diagnostic testing platform for Mycoplasma pneumonia, an infection of the lungs, and group A streptococcus, a type of bacteria often found in the [...]

Researchers from the University of Cincinnati are behind a startup that’s developing a medical device to help emergency doctors diagnose a severe type of headache that could be a warning sign for stroke.Xanthostat Diagnostics’ device would analyze cerebral spinal fluid to determine if patients are suffering from sentinel subarachnoid hemorrhage (SAH), a painful headache that [...]

Queen City Angels’ Chairman Tony Shipley testified before a House subcommittee last week on the value angel investing brings to the U.S. economy.Shipley represented the Angel Capital Association in making his statement to the House Committee on Small Business Subcommittee on Economic Growth, Tax and Capital Access, according to a statement from Cincinnati-based Queen City [...]

AtriCure (Nasdaq:ATRC) CEO David Drachman’s compensation package received a 64 percent boost to $1.9 million last year.The Cincinnati-based cardiac devicemaker paid Drachman about $1.5 million in stock and options and $450,000 in salary in 2011, according to a proxy statement AtriCure filed today.Drachman’s salary in 2010 was $412,000, with a total compensation of $1.1 million. [...]

Meridian Bioscience (NASDAQ:VIVO) has reached a deal to offer discounted prices for two molecular diagnostics tests to members of one of the nation’s largest healthcare group purchasing organizations.Cincinnati-area Meridian hopes the deal with Premier, a hospital-owned quality improvement alliance that boasts more than 2,500 hospital members, adds a spark to sales of two molecular diagnostic [...]

It’s a cliche in the venture capital industry that VC firms offer much more than money to their portfolio companies.But it’s certainly true that venture firms routinely provide their companies with networking opportunities, introductions to key opinion leaders, domain expertise and business development assistance, in general.A new Cincinnati venture fund that’s been launched to invest [...]

A pilot project from the Center for Medicare & Medicaid Innovation will funnel extra cash to primary care practices from both the federal government and private insurers.The federal government has selected seven regions across the nation to participate in the pilot program, including the Cincinnati and Dayton area in Southern Ohio. Officials with Cincinnati’s The [...]

A once-daily oral anemia drug from Akebia Therapeutics met its primary endpoint in a phase 2a trial of chronic kidney disease patients.The successful 42-day trial of the drug, now called AKB-6548, sets the stage for a longer 2b trial that would follow patients for six months, said Bill Daly, Akebia’s senior vice president of business [...]